The controversial question of whether or not to incarcerate patients with drug-resistant tuberculosis came under the spotlight at a workshop held at the Faculty of Health […]
Thanks to their new Discovery Foundation Academic Fellowships, Dr Hoosain Khalfey and Dr Greg Symons have the funding to continue their potentially ground-breaking studies of lung […]
In The Lancet today, Keertan Dheda and co-authors present an interesting report about early treatment outcomes of extensively drug-resistant (XDR) tuberculosis (resistant to isoniazid, rifampicin, any […]
TB is the most common serious opportunistic infection that HIV-positive South Africans contract. TB patients who are tested for HIV can be put on antiretroviral treatment […]
Data from Kwazulu Natal, South Africa, suggest that almost all patients with extensively drug-resistant (XDR) tuberculosis are HIV-positive, with a fatal outcome. Since, there are few […]
Although progress has been made to reduce global incidence of drug-susceptible tuberculosis, the emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis during the past decade […]
New findings by UCT’s Dr Richard van Zyl-Smit could up-end some widely-held tenets of tuberculosis testing. Based at the Lung Infection and Immunity Unit, Van Zyl-Smit, […]
Three specialists at UCT’s Lung Infection and Immunity Unit have won substantial US fellowships for their doctoral studies on tuberculosis. Download article Monday Paper, 26 October […]